TY - BOOK PY - 2011 DA - 2011// TI - Global tuberculosis control: WHO report 2011 PB - WHO CY - Geneva ID - ref1 ER - TY - STD TI - U.S. Global health policy country data. [http://www.globalhealthfacts.org/data/topic/map.aspx?ind=12] UR - http://www.globalhealthfacts.org/data/topic/map.aspx?ind=12 ID - ref2 ER - TY - BOOK PY - 2007 DA - 2007// TI - Strategic plan for TB 2007 to 2011 PB - National Department of Health CY - Pretoria ID - ref3 ER - TY - CHAP AU - Day, C. AU - Gray, A. AU - Budgell, E. ED - Padarath, A. ED - English, R. PY - 2011 DA - 2011// TI - Health and related indicators BT - South African Health Review 2011 PB - Health Systems Trust CY - Durban ID - Day2011 ER - TY - BOOK AU - Grimard, F. AU - Harling, G. PY - 2004 DA - 2004// TI - The Impact of Tuberculosis on Economic Growth PB - McGill University CY - Department of Economics ID - Grimard2004 ER - TY - BOOK PY - 2010 DA - 2010// TI - Delivery Agreement PB - National Department of Health CY - Pretoria ID - ref6 ER - TY - JOUR AU - Sáncheza, F. AU - López Colomésa, J. L. AU - Villarino, E. AU - Grosset, J. PY - 2011 DA - 2011// TI - New drugs for tuberculosis treatment JO - Enferm Infec Microbiol Clin VL - 29 UR - https://doi.org/10.1016/S0213-005X(11)70018-0 DO - 10.1016/S0213-005X(11)70018-0 ID - Sáncheza2011 ER - TY - STD TI - Treatment action group/i-base: 2011 pipeline report. 2011, New York: Treatment Action Group, [http://www.treatmentactiongroup.com] UR - http://www.treatmentactiongroup.com ID - ref8 ER - TY - JOUR AU - Gler, M. T. AU - Skripconoka, V. AU - Sanchez-Garavito, E. AU - Xiao, H. AU - Cabrera-Rivero, J. L. AU - Vargas-Vasquez, D. E. AU - Gao, M. AU - Awad, M. AU - Park, S. -. K. AU - Shim, T. S. AU - Suh, G. Y. AU - Danilovits, M. AU - Ogata, H. AU - Kurve, A. AU - Chang, J. AU - Suzuki, K. AU - Tupasi, T. AU - Koh, W. -. J. AU - Seaworth, B. AU - Geiter, L. J. AU - Wells, C. D. PY - 2012 DA - 2012// TI - Delamanid for multidrug-resistant pulmonary tuberculosis JO - NEJM VL - 66 UR - https://doi.org/10.1056/NEJMoa1112433 DO - 10.1056/NEJMoa1112433 ID - Gler2012 ER - TY - BOOK PY - 2003 DA - 2003// TI - TB Alliance Pipeline PB - TB Alliance CY - Geneva ID - ref10 ER - TY - JOUR AU - Stewart, J. J. AU - Allison, P. N. AU - Johnson, R. S. PY - 2001 DA - 2001// TI - Putting a price on biotechnology JO - Nat Biotechnol VL - 19 UR - https://doi.org/10.1038/nbt0901-813 DO - 10.1038/nbt0901-813 ID - Stewart2001 ER - TY - BOOK PY - 2001 DA - 2001// TI - The Economics of TB Drug Development PB - Global Alliance for TB CY - Geneva ID - ref12 ER - TY - JOUR AU - Gardner, C. A. T. AU - Acharya, T. AU - Pablos-Mendez, A. PY - 2005 DA - 2005// TI - The global alliance for tuberculosis drug development -accomplishments and future directions JO - Clin Chest Med VL - 26 UR - https://doi.org/10.1016/j.ccm.2005.02.008 DO - 10.1016/j.ccm.2005.02.008 ID - Gardner2005 ER - TY - BOOK AU - Mathieu, M. PY - 2005 DA - 2005// TI - Paraxel’s Pharmaceutical R&D statistical sourcebook 2005/2006 PB - Paraxel International Corporation CY - Boston ID - Mathieu2005 ER - TY - JOUR AU - DiMasi, J. A. AU - Hansen, R. W. AU - Grabowski, H. G. PY - 2003 DA - 2003// TI - The price of innovation: new estimates of drug development costs JO - J Health Econ VL - 22 UR - https://doi.org/10.1016/S0167-6296(02)00126-1 DO - 10.1016/S0167-6296(02)00126-1 ID - DiMasi2003 ER - TY - JOUR AU - DiMasi, J. A. AU - Hansen, R. W. AU - Grabowski, H. G. AU - Lasagna, L. PY - 1991 DA - 1991// TI - Cost of innovation in the pharmaceutical industry JO - J Health Econ VL - 10 UR - https://doi.org/10.1016/0167-6296(91)90001-4 DO - 10.1016/0167-6296(91)90001-4 ID - DiMasi1991 ER - TY - JOUR AU - DiMasi, J. A. AU - Hansen, R. W. AU - Grabowski, H. G. PY - 2005 DA - 2005// TI - Extraordinary claims require extraordinary evidence JO - J Health Econ VL - 24 UR - https://doi.org/10.1016/j.jhealeco.2005.07.002 DO - 10.1016/j.jhealeco.2005.07.002 ID - DiMasi2005 ER - TY - BOOK PY - 2011 DA - 2011// TI - Neglected disease research and development: is innovation under threat? PB - Policy Cures CY - London ID - ref18 ER - TY - BOOK AU - Jiménez-Levi, E. PY - 2011 DA - 2011// TI - Tuberculosis research and development: 2011 report on tuberculosis research funding trends, 2005–2010 PB - Treatment Action Group CY - New York ID - Jiménez-Levi2011 ER - TY - BOOK PY - 2012 DA - 2012// TI - Transforming individual successes into sustainable change to ensure health innovation for neglected patients: why an essential health R&D convention is needed PB - DNDi Policy Brief CY - Geneva ID - ref20 ER - TY - JOUR AU - Moran, M. AU - Guzman, J. AU - Ropars, A. -. L. AU - McDonald, A. AU - Jameson, N. AU - Omune, B. AU - Ryan, S. AU - Wu, L. PY - 2009 DA - 2009// TI - Neglected disease research and development: how much are we really spending? JO - PLoS Med VL - 6 UR - https://doi.org/10.1371/journal.pmed.1000030 DO - 10.1371/journal.pmed.1000030 ID - Moran2009 ER - TY - BOOK PY - 2012 DA - 2012// TI - Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination PB - WHO CY - Geneva ID - ref22 ER - TY - BOOK AU - Barsdorf, N. PY - 2012 DA - 2012// TI - South Africa’s Duty to Support Health Research for the Global Poor. Dissertation for the degree PhD thesis PB - Centre for International Health CY - University of Bergen ID - Barsdorf2012 ER - TY - BOOK PY - 2012 DA - 2012// TI - Public Search Tool PB - Policy Cures CY - London ID - ref24 ER - TY - BOOK PY - 2012 DA - 2012// TI - Health and Human Rights Section PB - WHO CY - Geneva ID - ref25 ER - TY - BOOK AU - Miller, R. PY - 2010 DA - 2010// TI - Globalizing Justice: The Ethics of Poverty and Power PB - Oxford University Press CY - New York UR - https://doi.org/10.1093/acprof:oso/9780199581986.001.0001 DO - 10.1093/acprof:oso/9780199581986.001.0001 ID - Miller2010 ER - TY - BOOK AU - Pogge, T. PY - 2002 DA - 2002// TI - World Poverty and Human Rights: Cosmopolitan Responsibilities and Reforms PB - Polity Press CY - Cambridge ID - Pogge2002 ER - TY - STD TI - Data on GDP and GERD obtained from the OECD statistical database.http://stats.oecd.org/, UR - http://stats.oecd.org/ ID - ref28 ER - TY - BOOK PY - 2001 DA - 2001// TI - Abuja Declaration on HIV/AIDS, Tuberculosis and Other Related Infectious Diseases. Document OAU/SPS/ABUJA/3 ID - ref29 ER - TY - BOOK PY - 2008 DA - 2008// TI - Monitoring Financial Flows for Health Research PB - Global Forum for Health Research CY - Geneva ID - ref30 ER - TY - BOOK PY - 2011 DA - 2011// TI - National Health Research Summit Report ID - ref31 ER - TY - JOUR AU - Walwyn, D. PY - 2010 DA - 2010// TI - Determining research and development expenditure targets based on an affordability index JO - Inter J Innov Technol Management VL - 7 UR - https://doi.org/10.1142/S0219877010001908 DO - 10.1142/S0219877010001908 ID - Walwyn2010 ER - TY - BOOK AU - Verbeek, A. AU - Lykogianni, E. PY - 2008 DA - 2008// TI - A time series analysis of the development in national R&D intensities and national public expenditures on R&D. Final study report for specific assignment 4: literature review, feasibility study, collection of field statistics, calculation of indicators, survey, conclusions PB - Rindicate CY - Brussels ID - Verbeek2008 ER - TY - BOOK AU - Godin, B. PY - 2003 DA - 2003// TI - The Most Cherished Indicator: Gross Domestic Expenditures on R&D. Project on the History and Sociology of S&T Statistics, Working Paper no. 22 PB - CSIIC CY - Quebec ID - Godin2003 ER - TY - JOUR AU - Wells, W. A. AU - Fan Ge, C. AU - Patel, N. AU - Oh, T. AU - Gardiner, E. AU - Kimerling, M. E. PY - 2011 DA - 2011// TI - Size and usage patterns of private TB drug markets in the high-burden countries JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0018964 DO - 10.1371/journal.pone.0018964 ID - Wells2011 ER -